Перейти к главному меню навигации Перейти к основному контенту Перейти к нижнему колонтитулу сайта

KORONAVIRUS INFEKSIYASI TUFAYLI SOCH TO'KILISHI VA DAVOLASH USULLARI

Аннотация

Soch to'kilishining sabablaridan biri bu stressdir. Global COVID-19 pandemiyasi ko'pchilik uchun shunday omilga aylandi. Ushbu infeksiya tufayli soch to'kilishining patogenezi hali yetarlicha o'rganilmaganligini hisobga olganda, ko'pchilik mualliflar infeksiyaning o'zi ham, u bilan bog'liq bo'lgan psixo-emotsional holat va o'tkaziladigan terapiya ham  diffuz soch to'kilishiga va androgenetik alopesiyaga olib kelishi mumkin degan teoriyani taklif qilishdi.

Ключевые слова

alopesiya, diffuz soch to'kilishi, telogen soch to'kilishi, COVID-19, o'simlik stimulyatorlari.

PDF

Библиографические ссылки

  1. Asghar F., Shamim N., Farooque U., Sheikh H., Aqeel R. Telogen Effluvium: A Review of the Literature. Cureus. 2020;12(5):e8320. doi: 10.7759/cureus.8320
  2. Freeman E.E., McMahon D.E., Fitzgerald M.E., French L.E., Thiers B.H., Hruza G.J. et al. The AAD COVID‐19 Registry: Crowdsourcing Dermatology in the Age of COVID‐19. J Am Acad Dermatol. 2020;83(2):509–510. doi: 10.1016/j.jaad.2020.04.045.
  3. Goren A., Vaño‐Galván S., Wambier C.G., McCoy J., Gomez-Zubiaur A., Moreno Arrones O.S. et al. A Preliminary Observation: Male Pattern Hair Loss among Hospitalized COVID‐19 Patients in Spain – A Potential Clue to the Role of Androgens in COVID‐19 Severity. J Cosmet Dermatol. 2020;19(7):1545–1547. doi: 10.1111/jocd.13443.
  4. Hoffmann M., Kleine‐Weber H., Schroeder S., Muller M.A., Drosten C., Pöhlmann S. et al. SARS‐CoV‐2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181(2):271.e8–280.e8. doi: 10.1016/j.cell.2020.02.052.
  5. Lei Y., Huang X., Bamu S., Lan Y.P., Lu J., Zeng F. Clinical Features of Imported Cases of Coronavirus Disease 2019 in Tibetan Patients in the Plateau area. Infect Dis Poverty. 2020;395(10223):497–506. doi: 10.21203/rs.3.rs-22978/v1.
  6. Li L.Q., Huang T., Wang Y.Q., Wang Z.P., Liang Y., Huang T.B. et al. COVID- 19 Patients’ Clinical Characteristics, Discharge Rate, and Fatality Rate of Meta-Analysis. J Med Virol. 2020;92(6):577–583. doi: 10.1002/ jmv.25757.
  7. Mungmungpuntipantip R., Wiwanitkit V. COVID‐19 and Cutaneous Manifestations. J Eur Acad Dermatol Venereol. 2020;34(6):e246–e246. doi: 10.1111/jdv.16483.
  8. Müller Ramos P., Ianhez M., Amante Miot H. Alopecia and Grey Hair Are Associated with COVID-19 Severity. Exp Dermatol. 2020;29(12):1250–1252. doi: 10.1111/exd.14220.
  9. Olds H., Liu J., Luk K., Lim H.W., Ozog D., Rambhatla P.V. Telogen Effluvium Associated with COVID-19 Infection. Dermatol Ther. 2021;34(2):e14761. doi: 10.1111/dth.14761.
  10. Recalcati S. Cutaneous Manifestations in COVID-19: A First Perspective. J Eur Acad Dermatol Venereol. 2020;34(5):e212–e213. https://doi.org/10.1111/ jdv.16387. 3.
  11. Sabharwal N., Sharifi N. HSD3B1 Genotypes Conferring Adrenal‐Restrictive and Adrenal‐Permissive Phenotypes in Prostate Cancer and Beyond. Endocrinology. 2019;160(9):2180–2188. doi: 10.1210/en.2019-00366.
  12. Wambier C.G., Vaño-Galván S., McCoy J., Gomez-Zubiaur A., Herrera S., Hermosa-Gelbard Á. et al. Androgenetic Alopecia Present in the Majority of Patients Hospitalized With COVID-19: The “Gabrin Sign”. J Am Acad Dermatol. 2020;83(2):680–682. doi: 10.1016/j. jaad.2020.05.079.
  13. Wollina U., Karadağ A.S., Rowland-Payne C., Chiriac A., Lotti T. Cutaneous Signs in COVID-19 Patients: A Review. Dermatol Ther. 2020;33(5):e13549. doi: 10.1111/dth.13549